Boston 3T joins UMass incubator

Boston 3T Biotechnologies, an early stage pharmaceutical company developing innovative cancer-treatment technology from its headquarters in Woburn, Mass., has joined the University of Massachusetts Dartmouth’s Advanced Technology & Manufacturing Center. More

To continue reading this article, please do one of the following.



technology

Boston 3T joins UMass incubator

THE SCIENTISTS who founded Boston 3T have used genetically modified cytokine-induced killer cells to create a cancer-treatment technology that serves as a T cell receptor gene during cancer therapy and is integrated into the cancer patient’s own cells.
Posted 1/22/14

DARTMOUTH – Boston 3T Biotechnologies, an early stage pharmaceutical company developing innovative cancer-treatment technology from its headquarters in Woburn, Mass., has joined the University of Massachusetts Dartmouth’s Advanced Technology & Manufacturing Center.

The UMass center is an incubator for emerging companies like Boston 3T, providing structure and resources to help them develop into technology and manufacturing leaders in New England and beyond.

“We are excited to add Boston 3T Biotechnologies to the ATMC portfolio,” said Paul Vigeant, director of the Advanced Technology & Manufacturing Center. “We look forward to Boston 3T Biotechnologies building upon its cutting edge, innovative treatment technology and making its own mark in its development of therapies to patients.”

The scientists who founded Boston 3T have used genetically modified cytokine-induced killer cells to create a cancer-treatment technology that serves as a T cell receptor gene during cancer therapy and is integrated into the cancer patient’s own cells. The engineered gene redirects the killer cells to the tumor tissues, thereby attacking the cancerous cells and helping to reverse the suppression of immune cells.

“Our drug discovery development covers various disciplines including virology, cell biology, and immunology, protein engineering, and cancer vaccines,” said Dr. Meijia Yang, president and CEO of Boston 3T Biotechnologies. “Boston 3T Biotechnologies is dutifully committed to the development of cell-base therapies for patients and becoming a demonstrated leader in the therapeutic discovery and manufacture sciences.”

Twelve companies in the clean energy, marine technology, biotechnology and life sciences, and software industries currently occupy space at the Advanced Technology & Manufacturing Center. The center has successfully graduated 15 companies, 80 percent of which have stayed in Massachusetts to help grow the local economy, according to UMass.

The Advanced Technology & Manufacturing Center saw annual sales of over $50 million in 2013, and to date its companies have generated more than 200 jobs.

Calendar
PBN Hosted
Events

See the List of 2014 Winners. And save the date - September 10th - for the 3rd Annual Fastest Growing & Innovative Companies program at Rosecliff Mansion in Newport.
  • Healthiest Employers
    Thank you to all who attended the 3rd Annual Healthiest Employers Luncheon today ...
Advertisement
Purchase Data
Book of Lists
Lists
Book of Lists cover
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.
Data icons
Data can be purchased as single lists, in either Excel or PDF format; the entire database of the published book, in Excel format; or a printed copy of the Book of Lists.
  • Purchase an e-File of a single list
  •  
  • Purchase an e-File of the entire Book of Lists database
  •  
  • Purchase a printed copy of the Book of Lists
  •  
    National
    Local
    Latest News
    Advertisement